FLASH-TB: an Application of Next-Generation CRISPR to Detect Drug Resistant Tuberculosis from Direct Sputum



Tram, Trinh Thi Bich, Ha, Vu Thi Ngoc, Trieu, Le Pham Tien, Ashton, Philip M, Crawford, Emily D, Thu, Do Dang Anh, Quang, Nguyen Le, Thwaites, Guy E, Walker, Timothy M, Anscombe, Catherine
et al (show 1 more authors) (2023) FLASH-TB: an Application of Next-Generation CRISPR to Detect Drug Resistant Tuberculosis from Direct Sputum. JOURNAL OF CLINICAL MICROBIOLOGY, 61 (4). e0163422-.

[img] Text
FLASH-TB an Application of Next-Generation CRISPR to Detect Drug Resistant Tuberculosis from Direct Sputum.pdf - Open Access published version

Download (1MB) | Preview

Abstract

Offering patients with tuberculosis (TB) an optimal and timely treatment regimen depends on the rapid detection of Mycobacterium tuberculosis (Mtb) drug resistance from clinical samples. Finding Low Abundance Sequences by Hybridization (FLASH) is a technique that harnesses the efficiency, specificity, and flexibility of the Cas9 enzyme to enrich targeted sequences. Here, we used FLASH to amplify 52 candidate genes probably associated with resistance to first- and second-line drugs in the Mtb reference strain (H37Rv), then detect drug resistance mutations in cultured Mtb isolates, and in sputum samples. 92% of H37Rv reads mapped to Mtb targets, with 97.8% of target regions covered at a depth ≥ 10X. Among cultured isolates, FLASH-TB detected the same 17 drug resistance mutations as whole genome sequencing (WGS) did, but with much greater depth. Among the 16 sputum samples, FLASH-TB increased recovery of Mtb DNA compared with WGS (from 1.4% [IQR 0.5-7.5] to 33% [IQR 4.6-66.3]) and average depth reads of targets (from 6.3 [IQR 3.8-10.5] to 1991 [IQR 254.4-3623.7]). FLASH-TB identified Mtb complex in all 16 samples based on IS<i>1081</i> and IS<i>6110</i> copies. Drug resistance predictions for 15/16 (93.7%) clinical samples were highly concordant with phenotypic DST for isoniazid, rifampicin, amikacin, and kanamycin [15/15 (100%)], ethambutol [12/15 (80%)] and moxifloxacin [14/15 (93.3%)]. These results highlighted the potential of FLASH-TB for detecting Mtb drug resistance from sputum samples.

Item Type: Article
Uncontrolled Keywords: CRISPR, drug resistance, FLASH, Mycobacterium tuberculosis, RNA guide, sequencing
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Infection, Veterinary and Ecological Sciences
Depositing User: Symplectic Admin
Date Deposited: 18 Sep 2023 08:28
Last Modified: 18 Sep 2023 08:29
DOI: 10.1128/jcm.01634-22
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3172790